Aceto Corporation execute its first generic biopharmaceutical agreement
Aceto Corporation announced that it signed an agreement with Three Rivers Pharmaceuticals, LLC to bring three generic biopharmaceutical products to market.
Under the agreement, Aceto will source the active pharmaceutical ingredients, manage the regulatory and quality control functions of production, and supply the final dosage form of the products to Three Rivers. Three Rivers will file applications with the appropriate regulatory agencies and market the products in the U.S., Europe and Japan. Aceto anticipates Three Rivers will submit regulatory applications within the next year, with commercialization of the products expected in 2007.
The agreement provides for revenue sharing between the two companies based on Three Rivers' final selling prices, and will continue for a minimum term of ten years from the date of initial commercial sales.
Other news from the department business & finance
